The Use of Brodalumab in Three Patients with Psoriasis and Psychiatric Comorbidities

Brodalumab, a first-in-class interleukin-17 (IL-17) receptor blocker, carries a black box warning for suicidal ideation and behavior, yet it is also one of the most powerful biologic agents in our armamentarium. We wish to highlight three patients with moderate-to-severe psoriasis and comorbid depre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Aesthet Dermatol
Main Authors: Rivera-Oyola, Ryan, Stanger, Roselyn, Litchman, Graham H, Thibodeaux, Quinn, Koo, John, Fried, Richard, Goldenberg, Gary, Han, George, Hsu, Sylvia, Kircik, Leon, Knuckles, Melissa, Murina, Andrea, Weinberg, Jeffrey, Wu, Jashin J., Lebwohl, Mark
Formato: Artigo
Idioma:Inglês
Publicado em: Matrix Medical Communications 2020
Assuntos:
Emerging Authors in Dermatology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7819587/
https://ncbi.nlm.nih.gov/pubmed/33488920
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados